GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Total Assets

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Total Assets : ¥2,830 Mil (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Total Assets?

Jiangsu Lianhuan Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥2,830 Mil.

During the past 12 months, Jiangsu Lianhuan Pharmaceutical Co's average Total Assets Growth Rate was 5.70% per year. During the past 3 years, the average Total Assets Growth Rate was 12.50% per year. During the past 5 years, the average Total Assets Growth Rate was 16.90% per year. During the past 10 years, the average Total Assets Growth Rate was 20.20% per year.

During the past 13 years, Jiangsu Lianhuan Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 36.10%. The lowest was 5.90%. And the median was 16.80%.

Total Assets is connected with ROA %. Jiangsu Lianhuan Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 4.58%. Total Assets is also linked to Revenue through Asset Turnover. Jiangsu Lianhuan Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.19.


Jiangsu Lianhuan Pharmaceutical Co Total Assets Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Lianhuan Pharmaceutical Co Total Assets Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,889.60 2,051.59 2,354.80 2,714.94 2,855.70

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,706.95 2,756.15 2,805.47 2,855.70 2,829.97

Jiangsu Lianhuan Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Jiangsu Lianhuan Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1517.31+1338.392
=2,856

Jiangsu Lianhuan Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=1554.228+1275.745
=2,830

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Lianhuan Pharmaceutical Co  (SHSE:600513) Total Assets Explanation

Total Assets is connected with ROA %.

Jiangsu Lianhuan Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=130.18/( (2855.702+2829.973)/ 2 )
=130.18/2842.8375
=4.58 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Jiangsu Lianhuan Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=528.459/( (2855.702+2829.973)/ 2 )
=528.459/2842.8375
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Jiangsu Lianhuan Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Business Description

Traded in Other Exchanges
N/A
Address
No. 21 Wenfeng Road, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225009
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.
Executives
Chu Qing Song senior management
Xia Chun Lai Director
Pan He Ping Directors, senior managers
Niu Ben senior management
Wu Wen Ge Director
Zhu Yong Jun senior management
Qian Zhen Hua Director
Shen Yi senior management
Huang Wen Tao senior management
Zhou Jun senior management
Tu Bin senior management
Qin Xiong Jian senior management

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Headlines

No Headlines